U.S., Dec. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07290205) titled 'Remimazolam NeuroImaging' on Dec. 12.
Brief Summary: This is a single-arm functional MRI study that will determine the effects of remimazolam on cognition and brain activity and connectivity at rest, during noxious stimulation, and during a memory encoding task
Study Start Date: March 01, 2026
Study Type: INTERVENTIONAL
Condition:
Anesthesia
Pain
Remimazolam
Intervention:
DRUG: Remimazolam
Subjects in this group will receive an intravenous infusion of this drug, during a portion of the study.
DEVICE: Peripheral Nerve Stimulation
Experimental acute pain stimulus will be delivered using a nerve stimulator. These painful shock...